Peplin

2021年9月15日

纽约，2021年9月15日/美通社/——美国皮肤协会(ASA)今天宣布，Eugene Bauer，医学博士将加入其董事会。纽约，2021年9月15日/美通社/——美国皮肤协会(ASA)今天宣布，医学博士Eugene Bauer将加入其董事会。他是Dermira, Inc.(一家生物技术公司，最近被Eli Lilly and company收购)的联合创始人、首席医疗官和董事会成员。“我们很荣幸地宣布尤金·鲍尔博士加入ASA董事会。Bauer博士在皮肤病学和制药行业的经验将是我们董事会的巨大资产，”ASA主席Howard P. Milstein说。“鲍尔博士是我们董事会的杰出成员!我们期待着与他合作，继续为我们的重要使命而努力，为那些患有皮肤病的人提供希望，”ASA主席大卫·诺里斯博士说。在制药行业开始职业生涯之前，鲍尔博士曾担任斯坦福大学皮肤病学系主任(1988-1995)和医学院院长(1995-2001)。他曾担任美国国立卫生研究院(NIH)资助的研究员25年，并为NIH的许多咨询小组服务。他曾入选多个荣誉学会，包括美国国家医学科学院。 Prior to founding Dermira, Dr. Bauer served as a member of the board of directors of Peplin, Inc., where he also was its President and Chief Medical Officer, until Peplin's acquisition by LEO Pharma in 2009. During 2004-2008, Dr. Bauer was Chief Executive Officer of Neosil, Inc., a clinical-stage dermatology company, acquired by Peplin, Inc., in 2008. Prior to that, he was co-founder and member of the Board of Directors at Connetics, a commercial dermatology company. ABOUT AMERICAN SKIN ASSOCIATIONASA is a unique collaboration of patients, families, advocates, physicians and scientists, and has evolved over thirty-four years into a leading force in efforts to defeat melanoma, skin cancer and important inflammatory and genetic skin diseases. Established to serve the now more than 100 million Americans - one third of the U.S. population - afflicted with skin disorders, the organization's mission remains to: advance research, champion skin health - particularly among children, and drive public awareness about skin disease. For more information, visit American Skin Association View original content to download multimedia: https://www.prnewswire.com/news-releases/american-skin-association-announces-new-board-member-eugene-a-bauer-md-301377815.html SOURCE American Skin Association